Clinical Trial Update: Pregablin for Anxiety-comorbidity in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating pregabalin for anxiety comorbidity in patients with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Schizophrenia

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: University of Aarhus | Conditions: Schizophrenia, Anxiety-comorbidity to Schizophrenia | Phase 4 | Status: COMPLETED